Business · 10/03/2005
FDA Publishes Guidance for Drug Metabolizing Enzyme Genotyping Systems
The FDA has released a guidance document outlining requirements for drug metabolizing enzyme genotyping systems, which are now classified as Class II devices subject to special controls, and will remain subject to public comment.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →